Tolvaptan (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tolvaptan" in Serbian language version.

refsWebsite

Global rank Serbian rank

4^th place

8^th place

2^nd place

4^th place

1^st place

low place

3,358^th place

3,011^th place

1,961^st place

doi.org

Shoaf S; Elizari M; Wang; et al. (2005). „Tolvaptan administration does not affect steady state amiodarone concentrations in patients with cardiac arrhythmias”. J Cardiovasc Pharmacol Ther. 10 (3): 165—71. PMID 16211205. doi:10.1177/107424840501000304.
Gheorghiade M; Gattis W; O'Connor C; et al. (2004). „Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial”. Journal of the American Medical Association. 291 (16): 1963—71. PMID 15113814. doi:10.1001/jama.291.16.1963.

Shoaf S; Elizari M; Wang; et al. (2005). „Tolvaptan administration does not affect steady state amiodarone concentrations in patients with cardiac arrhythmias”. J Cardiovasc Pharmacol Ther. 10 (3): 165—71. PMID 16211205. doi:10.1177/107424840501000304.
Gheorghiade M; Gattis W; O'Connor C; et al. (2004). „Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial”. Journal of the American Medical Association. 291 (16): 1963—71. PMID 15113814. doi:10.1001/jama.291.16.1963.

WHO International Working Group for Drug Statistics Methodology (27. 8. 2008). „ATC/DDD Classification (FINAL): New ATC 5th level codes”. WHO Collaborating Centre for Drug Statistics Methodology. Архивирано из оригинала 06. 05. 2008. г. Приступљено 5. 9. 2008.

WHO International Working Group for Drug Statistics Methodology (27. 8. 2008). „ATC/DDD Classification (FINAL): New ATC 5th level codes”. WHO Collaborating Centre for Drug Statistics Methodology. Архивирано из оригинала 06. 05. 2008. г. Приступљено 5. 9. 2008.